Why Rocket Lab Stock Plummeted 36.1% Last Month But Is Soaring in August

Rocket Lab shares fell 36.1% in July as investors cut valuation premiums on growth-dependent space stocks, alongside a risk-off backdrop tied to intensifying geopolitical tensions and expectations of higher inflation/interest rates. The company partially offset the drawdown with contract wins, including a $266M U.S. Space Force award and an August upswing of +27.5% backed by a new deal worth up to $397M for low-latency satellite threat-detection. Despite the rebound, the stock remains highly volatile, reflecting sentiment-driven rerating rather than clear deterioration in fundamentals.

Analysis

RKLB is still trading like a duration asset, not a business with a visible cash-flow bridge. The recent rebound is less about fundamental step-change than a reset in positioning: when real rates and geopolitical inflation fears rise, investors cut exposure to pre-profit, long-cycle names first, and space gets hit harder because the terminal value sits far out on Neutron execution.

The real signal in the new award is not revenue today, but validation that Rocket Lab can compete for higher-trust government missions, which widens the addressable market beyond small-launch reputation. That helps sentiment across the space stack, but it is also a trap: the market may be extrapolating a prime-contractor status that still depends on flawless execution, on-time launches, and working capital discipline over the next 12-18 months.

Winners are likely RKLB’s direct supply-chain counterparties and any defense-space firms with near-term cash generation; losers are the broader space beta basket if Neutron slips or if Treasury yields re-rate higher. The contrarian view is that the move may be underpinned by narrative, not earnings power: until the company proves repeatable launch cadence and converts backlog into gross margin, upside is capped by dilution and multiple compression risk. Falsifiers are simple: a Neutron delay, weaker government funding visibility, or a renewed spike in 10-year yields.

Key Decisions for Investors

• Buy RKLB only on pullbacks after the contract headline fades; use a 1-3 month horizon and keep size modest because the stock is still a duration trade with execution risk, not a cash-flow compounder.
• Pair trade: long RKLB / short a space-basket proxy such as SPCX if available, to isolate company-specific contract validation while hedging sector de-rating from rates or risk-off flows.
• Do not chase the August squeeze; wait for confirmation on Neutron milestones and any update to launch timing. If milestones slip, expect multiple compression to dominate backlog optimism.
• Set a risk alert on 10-year Treasury yields: a sustained move higher would likely pressure RKLB first among the watchlist, making it the cleanest candidate for de-risking.
• If management signals financing needs before Neutron cash conversion, consider fading the rally rather than adding exposure; dilution would quickly offset the headline value of the award.